CAMP4 Therapeutics Corp (CAMP)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$4.41-1.78%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · CAMP
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | |
|---|---|---|---|---|---|
| Revenues | |||||
| Revenues | — | 3.5 | 0.7 | 0.4 | — |
| Total Revenues | — | 3.5 | 0.7 | 0.4 | — |
| Operating Expenses & Income | |||||
| R&D Expenses | 38.7 | 38.2 | 38.8 | 40.6 | — |
| Operating Income | (52.9) | (52.6) | (53.1) | (51.9) | — |
| Earnings from Continuing Operations | |||||
| Interest & Investment Income | 2.9 | 2.2 | 1.3 | 2.8 | — |
| Other Non-Operating Income / Expenses | (54.4) | (27.8) | 1.3 | 2.6 | — |
| Asset Writedown | — | 0.5 | — | — | — |
| Income Tax Expense | — | — | — | 0.0 | — |
| Net Income | |||||
| Net Income | (107.2) | (80.4) | (51.8) | (49.3) | — |
| Per Share | |||||
| Basic EPS | (1.85) | (2.65) | (11.04) | (124.80) | — |
| Diluted EPS | (1.85) | (2.65) | (11.04) | (124.80) | — |
| Basic Weighted Avg Shares | 57.9 | 30.4 | 4.7 | 0.4 | — |
| Diluted Weighted Avg Shares | 57.9 | 30.4 | 4.7 | 0.4 | — |
| Supplemental | |||||
| EBITDA | — | (51.0) | (51.6) | (50.3) | — |
| EBIT | (52.9) | (52.6) | (53.1) | (51.9) | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.